- Repeated Methylglyoxal Treatment Depletes Dopamine in the Prefrontal Cortex, and Causes Memory Impairment and Depressive-Like Behavior in Mice
Jozimar Carlos Szczepanik et al, 2020, Neurochemical Research CrossRef - Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises
Paulo Matafome et al, 2017, Medicinal Research Reviews CrossRef - Nonenzymatic Posttranslational Protein Modifications: Mechanism and Associated Disease Pathologies
Sheeza Khan et al, 2019, Protein Modificomics CrossRef - The formation of the salt and neutral molecule cocrystal from equimolar solution of heliamine and bicyclo[2.2.1]hept-5-ene-endo-2,3-dicarboxylic acid
Svitlana V. Shishkina et al, 2019, Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials CrossRef - PKM2-mediated neuronal hyperglycolysis enhances the risk of Parkinson's disease in diabetic rats
Ya Zhao et al, 2023, Journal of Pharmaceutical Analysis CrossRef - Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
Paula A. Q. Videira et al, 2018, Frontiers in Neuroscience CrossRef - Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases
C. G. Schalkwijk et al, 2020, Physiological Reviews CrossRef - Early AGEing and metabolic diseases: is perinatal exposure to glycotoxins programming for adult-life metabolic syndrome?
Flávio A Francisco et al, 2021, Nutrition Reviews CrossRef - Isolation and Sequencing of Salsolinol Synthase, an Enzyme Catalyzing Salsolinol Biosynthesis
Xuechai Chen et al, 2018, ACS Chemical Neuroscience CrossRef - Glycation in Parkinson's disease and Alzheimer's disease
Hugo Vicente Miranda et al, 2016, Movement Disorders CrossRef - Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
Sourav De et al, 2024, Journal of the Taiwan Institute of Chemical Engineers CrossRef - On the Relationship between Energy Metabolism, Proteostasis, Aging and Parkinson’s Disease: Possible Causative Role of Methylglyoxal and Alleviative Potential of Carnosine
Alan R. Hipkiss, 2017, Aging and disease CrossRef - The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
Niklas Reich et al, 2022, Frontiers in Neuroscience CrossRef - Glycotoxins: Dietary and Metabolic Origins; Possible Amelioration of Neurotoxicity by Carnosine, with Special Reference to Parkinson’s Disease
Alan R. Hipkiss, 2018, Neurotoxicity Research CrossRef - The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality
Jyotiska Chaudhuri et al, 2018, Cell Metabolism CrossRef - Behavioral consequences of the downstream products of ethanol metabolism involved in alcohol use disorder
Otto T. Holbrook et al, 2022, Neuroscience & Biobehavioral Reviews CrossRef - Novel Synthesis of 4-Benzylidene-2-((1-phenyl-3,4-dihydroisoquinoline-2(1H)-yl)methyl) oxazol-5(4H)-one Derivatives Using 1,2,3,Tetrahydroisoquinoline and their Antimicrobial Activity
Nalla Krishna Rao et al, 2020, Current Organic Synthesis CrossRef - Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
Francesca Chiara Pignalosa et al, 2021, International Journal of Molecular Sciences CrossRef - The Adverse Influences of Sleep Disorders on Working Memory May Be Mediated by Changes in Carbohydrate Metabolism
Yu. V. Ukraintseva et al, 2023, Neuroscience and Behavioral Physiology CrossRef - Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway
Justine Renaud et al, 2018, Neurobiology of Aging CrossRef - The expanding impact of methylglyoxal on behavior-related disorders
Gudrian R.L. de Almeida et al, 2023, Progress in Neuro-Psychopharmacology and Biological Psychiatry CrossRef - Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
Fauze Camargo Maluf et al, 2019, Parkinson's Disease CrossRef